Validation of the Korean Version of the SARC-F Questionnaire to Assess Sarcopenia: Korean Frailty and Aging Cohort Study

The SARC-F is a simple sarcopenia screening tool comprising 5 assessment items: strength, assistance walking, rising from a chair, climbing stairs, and falls. The present study aimed to examine the validation of the Korean version of SARC-F for elderly individuals residing in communities. From the f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Medical Directors Association 2018-01, Vol.19 (1), p.40-45.e1
Hauptverfasser: Kim, Sunyoung, Kim, Miji, Won, Chang Won
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 45.e1
container_issue 1
container_start_page 40
container_title Journal of the American Medical Directors Association
container_volume 19
creator Kim, Sunyoung
Kim, Miji
Won, Chang Won
description The SARC-F is a simple sarcopenia screening tool comprising 5 assessment items: strength, assistance walking, rising from a chair, climbing stairs, and falls. The present study aimed to examine the validation of the Korean version of SARC-F for elderly individuals residing in communities. From the first year baseline data of Korean Frailty and Aging Cohort Study, a total of 1222 elderly individuals (70 years and older) who met the study's selection criteria were included in the analysis. The SARC-F was translated into the Korean language in a culturally responsive way. The total score was calculated by adding the scores on the 5 items. The participants were divided into 2 groups according to the total score (SARC-F
doi_str_mv 10.1016/j.jamda.2017.07.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1933228401</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1525861017304048</els_id><sourcerecordid>1933228401</sourcerecordid><originalsourceid>FETCH-LOGICAL-c425t-a8e1417d01f3ec9e391458c745daf32969caecb2f86d757e25edb360d4232af53</originalsourceid><addsrcrecordid>eNp9kFtr2zAUgMVYWbOsv6BQ9LgXp7pYsj3YQwjNVhooXdq-ihPpuFVwrExyxvLvZzdp6dPggMThO7ePkHPOJpxxfbmerGHjYCIYLyasD6Y_kBFXsswqWaiPw1-orNScnZLPKa0Z69FKfyKnoixzqYQekb-P0HgHnQ8tDTXtnpHehIjQ0keM6V12Of01y-b0bodpgFvwEWkX6DQlTIkuIdqwxdbDt9cG8wi-6fYUWkenT759orPwHGJHl93O7b-QkxqahGfHd0we5lf3s5_Z4vbH9Wy6yGwuVJdBiTznhWO8lmgrlBXPVWmLXDmopah0ZQHtStSldoUqUCh0K6mZy4UUUCs5Jl8Pfbcx_B6WNxufLDYNtBh2yfBKSiHKnPEelQfUxpBSxNpso99A3BvOzKDcrM2LcjMoN6wPpvuqi-OA3WqD7q3m1XEPfD8A2J_5x2M0yXpsLbpeoe2MC_6_A_4BqoaTLg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1933228401</pqid></control><display><type>article</type><title>Validation of the Korean Version of the SARC-F Questionnaire to Assess Sarcopenia: Korean Frailty and Aging Cohort Study</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Kim, Sunyoung ; Kim, Miji ; Won, Chang Won</creator><creatorcontrib>Kim, Sunyoung ; Kim, Miji ; Won, Chang Won</creatorcontrib><description>The SARC-F is a simple sarcopenia screening tool comprising 5 assessment items: strength, assistance walking, rising from a chair, climbing stairs, and falls. The present study aimed to examine the validation of the Korean version of SARC-F for elderly individuals residing in communities. From the first year baseline data of Korean Frailty and Aging Cohort Study, a total of 1222 elderly individuals (70 years and older) who met the study's selection criteria were included in the analysis. The SARC-F was translated into the Korean language in a culturally responsive way. The total score was calculated by adding the scores on the 5 items. The participants were divided into 2 groups according to the total score (SARC-F &lt;4 vs SARC-F ≥4), and its correlations with various factors including walking speed, hand grip, ability to perform everyday activities, and health-related quality of life, were examined by sex. In addition, the tool's validity was analyzed by comparing it with the European, international, and Asian sarcopenia working group diagnostic criteria for sarcopenia. The prevalence of sarcopenia according to the SARC-F was 4.2% in among men and 15.3% in women. The sensitivity of the SARC-F was low compared with the European, international, and Asian criteria of sarcopenia [male (M): 11%–60%, female (F): 28%–34%]. However, SARC-F showed a high specificity (M: 96.6%–98%, F: 85%–87.7%) and a high negative predictive value (M: 89.2%–99.3%, F: 88.5%–98.4%). The participants in the SARC-F ≥4 group had poorer grip strength, slower walking speed, poorer physical performance, poorer cognitive function, and a lower quality of life (a high EuroQol-5 dimension score) than the participants in the SARC-F &lt;4 group. The Korean language version of SARC-F showed a high specificity and high negative predictive value. As such, the tool is useful for briefly ruling out sarcopenia in a clinical setting. In addition, diagnosis of sarcopenia using the SARC-F was found to be associated with physical performance, cognitive function, and the quality of life.</description><identifier>ISSN: 1525-8610</identifier><identifier>EISSN: 1538-9375</identifier><identifier>DOI: 10.1016/j.jamda.2017.07.006</identifier><identifier>PMID: 28843526</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>frailty ; SARC-F ; Sarcopenia ; screening</subject><ispartof>Journal of the American Medical Directors Association, 2018-01, Vol.19 (1), p.40-45.e1</ispartof><rights>2017 AMDA – The Society for Post-Acute and Long-Term Care Medicine</rights><rights>Copyright © 2017 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c425t-a8e1417d01f3ec9e391458c745daf32969caecb2f86d757e25edb360d4232af53</citedby><cites>FETCH-LOGICAL-c425t-a8e1417d01f3ec9e391458c745daf32969caecb2f86d757e25edb360d4232af53</cites><orcidid>0000-0003-4115-4455</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1525861017304048$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28843526$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Sunyoung</creatorcontrib><creatorcontrib>Kim, Miji</creatorcontrib><creatorcontrib>Won, Chang Won</creatorcontrib><title>Validation of the Korean Version of the SARC-F Questionnaire to Assess Sarcopenia: Korean Frailty and Aging Cohort Study</title><title>Journal of the American Medical Directors Association</title><addtitle>J Am Med Dir Assoc</addtitle><description>The SARC-F is a simple sarcopenia screening tool comprising 5 assessment items: strength, assistance walking, rising from a chair, climbing stairs, and falls. The present study aimed to examine the validation of the Korean version of SARC-F for elderly individuals residing in communities. From the first year baseline data of Korean Frailty and Aging Cohort Study, a total of 1222 elderly individuals (70 years and older) who met the study's selection criteria were included in the analysis. The SARC-F was translated into the Korean language in a culturally responsive way. The total score was calculated by adding the scores on the 5 items. The participants were divided into 2 groups according to the total score (SARC-F &lt;4 vs SARC-F ≥4), and its correlations with various factors including walking speed, hand grip, ability to perform everyday activities, and health-related quality of life, were examined by sex. In addition, the tool's validity was analyzed by comparing it with the European, international, and Asian sarcopenia working group diagnostic criteria for sarcopenia. The prevalence of sarcopenia according to the SARC-F was 4.2% in among men and 15.3% in women. The sensitivity of the SARC-F was low compared with the European, international, and Asian criteria of sarcopenia [male (M): 11%–60%, female (F): 28%–34%]. However, SARC-F showed a high specificity (M: 96.6%–98%, F: 85%–87.7%) and a high negative predictive value (M: 89.2%–99.3%, F: 88.5%–98.4%). The participants in the SARC-F ≥4 group had poorer grip strength, slower walking speed, poorer physical performance, poorer cognitive function, and a lower quality of life (a high EuroQol-5 dimension score) than the participants in the SARC-F &lt;4 group. The Korean language version of SARC-F showed a high specificity and high negative predictive value. As such, the tool is useful for briefly ruling out sarcopenia in a clinical setting. In addition, diagnosis of sarcopenia using the SARC-F was found to be associated with physical performance, cognitive function, and the quality of life.</description><subject>frailty</subject><subject>SARC-F</subject><subject>Sarcopenia</subject><subject>screening</subject><issn>1525-8610</issn><issn>1538-9375</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kFtr2zAUgMVYWbOsv6BQ9LgXp7pYsj3YQwjNVhooXdq-ihPpuFVwrExyxvLvZzdp6dPggMThO7ePkHPOJpxxfbmerGHjYCIYLyasD6Y_kBFXsswqWaiPw1-orNScnZLPKa0Z69FKfyKnoixzqYQekb-P0HgHnQ8tDTXtnpHehIjQ0keM6V12Of01y-b0bodpgFvwEWkX6DQlTIkuIdqwxdbDt9cG8wi-6fYUWkenT759orPwHGJHl93O7b-QkxqahGfHd0we5lf3s5_Z4vbH9Wy6yGwuVJdBiTznhWO8lmgrlBXPVWmLXDmopah0ZQHtStSldoUqUCh0K6mZy4UUUCs5Jl8Pfbcx_B6WNxufLDYNtBh2yfBKSiHKnPEelQfUxpBSxNpso99A3BvOzKDcrM2LcjMoN6wPpvuqi-OA3WqD7q3m1XEPfD8A2J_5x2M0yXpsLbpeoe2MC_6_A_4BqoaTLg</recordid><startdate>201801</startdate><enddate>201801</enddate><creator>Kim, Sunyoung</creator><creator>Kim, Miji</creator><creator>Won, Chang Won</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4115-4455</orcidid></search><sort><creationdate>201801</creationdate><title>Validation of the Korean Version of the SARC-F Questionnaire to Assess Sarcopenia: Korean Frailty and Aging Cohort Study</title><author>Kim, Sunyoung ; Kim, Miji ; Won, Chang Won</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c425t-a8e1417d01f3ec9e391458c745daf32969caecb2f86d757e25edb360d4232af53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>frailty</topic><topic>SARC-F</topic><topic>Sarcopenia</topic><topic>screening</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Sunyoung</creatorcontrib><creatorcontrib>Kim, Miji</creatorcontrib><creatorcontrib>Won, Chang Won</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Medical Directors Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Sunyoung</au><au>Kim, Miji</au><au>Won, Chang Won</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Validation of the Korean Version of the SARC-F Questionnaire to Assess Sarcopenia: Korean Frailty and Aging Cohort Study</atitle><jtitle>Journal of the American Medical Directors Association</jtitle><addtitle>J Am Med Dir Assoc</addtitle><date>2018-01</date><risdate>2018</risdate><volume>19</volume><issue>1</issue><spage>40</spage><epage>45.e1</epage><pages>40-45.e1</pages><issn>1525-8610</issn><eissn>1538-9375</eissn><abstract>The SARC-F is a simple sarcopenia screening tool comprising 5 assessment items: strength, assistance walking, rising from a chair, climbing stairs, and falls. The present study aimed to examine the validation of the Korean version of SARC-F for elderly individuals residing in communities. From the first year baseline data of Korean Frailty and Aging Cohort Study, a total of 1222 elderly individuals (70 years and older) who met the study's selection criteria were included in the analysis. The SARC-F was translated into the Korean language in a culturally responsive way. The total score was calculated by adding the scores on the 5 items. The participants were divided into 2 groups according to the total score (SARC-F &lt;4 vs SARC-F ≥4), and its correlations with various factors including walking speed, hand grip, ability to perform everyday activities, and health-related quality of life, were examined by sex. In addition, the tool's validity was analyzed by comparing it with the European, international, and Asian sarcopenia working group diagnostic criteria for sarcopenia. The prevalence of sarcopenia according to the SARC-F was 4.2% in among men and 15.3% in women. The sensitivity of the SARC-F was low compared with the European, international, and Asian criteria of sarcopenia [male (M): 11%–60%, female (F): 28%–34%]. However, SARC-F showed a high specificity (M: 96.6%–98%, F: 85%–87.7%) and a high negative predictive value (M: 89.2%–99.3%, F: 88.5%–98.4%). The participants in the SARC-F ≥4 group had poorer grip strength, slower walking speed, poorer physical performance, poorer cognitive function, and a lower quality of life (a high EuroQol-5 dimension score) than the participants in the SARC-F &lt;4 group. The Korean language version of SARC-F showed a high specificity and high negative predictive value. As such, the tool is useful for briefly ruling out sarcopenia in a clinical setting. In addition, diagnosis of sarcopenia using the SARC-F was found to be associated with physical performance, cognitive function, and the quality of life.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28843526</pmid><doi>10.1016/j.jamda.2017.07.006</doi><orcidid>https://orcid.org/0000-0003-4115-4455</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1525-8610
ispartof Journal of the American Medical Directors Association, 2018-01, Vol.19 (1), p.40-45.e1
issn 1525-8610
1538-9375
language eng
recordid cdi_proquest_miscellaneous_1933228401
source Elsevier ScienceDirect Journals Complete
subjects frailty
SARC-F
Sarcopenia
screening
title Validation of the Korean Version of the SARC-F Questionnaire to Assess Sarcopenia: Korean Frailty and Aging Cohort Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T07%3A59%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Validation%20of%20the%20Korean%20Version%20of%20the%20SARC-F%20Questionnaire%20to%20Assess%20Sarcopenia:%20Korean%20Frailty%20and%20Aging%20Cohort%20Study&rft.jtitle=Journal%20of%20the%20American%20Medical%20Directors%20Association&rft.au=Kim,%20Sunyoung&rft.date=2018-01&rft.volume=19&rft.issue=1&rft.spage=40&rft.epage=45.e1&rft.pages=40-45.e1&rft.issn=1525-8610&rft.eissn=1538-9375&rft_id=info:doi/10.1016/j.jamda.2017.07.006&rft_dat=%3Cproquest_cross%3E1933228401%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1933228401&rft_id=info:pmid/28843526&rft_els_id=S1525861017304048&rfr_iscdi=true